Significance of BCR-ABL Transcripts in Bone Marrow Aspirates of Philadelphia-Negative Essential Thrombocythemia Patients

References

• Fialkow P. J., Faguet G. B., Jacobson R. J., Raidya K., Murphy S. Evidance that essential thrombocythaemia is a clonal disorder with origin in multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J. R., Heisterkamp N., De Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 1985; 315: 550–555
   PubMed Web of Science ®Google Scholar
• Ben-Neriah Y., Daley G. O., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia specific p210 protein is the product of the BCR/ABL hybrid gene. Science 1986; 233: 212–214
   PubMed Web of Science ®Google Scholar
• De Klein A. Oncogene activation by chromosomal rearrangement in chronic myeloid leukemia. Mutat. Res. 1987; 186: 161–172
   PubMed Web of Science ®Google Scholar
• Melo J. V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375–2384
   PubMed Web of Science ®Google Scholar
• Bedi A., Zehnbauer B. A., Barber J. P., Sharkis S., Jones R. J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038–2044
   PubMed Web of Science ®Google Scholar
• McGahon A., Bissonnette R., Schmitt M., Cotter K. M., Green D. R., Cotter T. G. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994; 83: 1179–1187
   PubMed Web of Science ®Google Scholar
• Saglio G., Guerrasio A., Rosso C., Zaccaria A., Tassinari A., Serra A., Rege-Cambrin G., Mazza U., Gavosto F. New type of BCR-ABL junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990; 76: 1819–1824
   PubMed Web of Science ®Google Scholar
• Wada H., Mizutani S., Nishimura J., Usuki Y., Kohsaki M., Komai M., Keneko H., Sakamoto S., Delia D., Kanamaru A., Kakishita E. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR-ABL fusion protein. Cancer Res. 1995; 55: 3192–3196
   PubMed Web of Science ®Google Scholar
• Pane F., Frigeri F., Sinodna M., Luciano L., Ferrara F., Cimino R., Meloni G., Saglio G., Salvatore F., Rotoli B. Neutrophilic chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR-ABL with c3/a2 junction). Blood 1996; 88: 2410–2414
   PubMed Web of Science ®Google Scholar
• Yamagata T., Mitani K., Kanda Y., Yazaki Y., Hirai H. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous lekemia. Brit. J. Haemal. 1996; 94: 370–372
   PubMed Web of Science ®Google Scholar
• Melo J. V., Myint H., Galton D. A.G., Goldman J. M. P190 BCR-ABL chronic myeloid leukemia: the missing like with chronic myelomonocytic leukemia. Leukemia 1994; 8: 208–211
   PubMed Web of Science ®Google Scholar
• El-Kassar N., Hetet G., Brie're J., Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets. Blood 1997; 89: 128–134
   PubMed Web of Science ®Google Scholar
• Douer D., Fabian I., Cline M. J. Circulating pluripotent haematopoietic cells in patients with myeloproliferative disorders. Br. J. Haematol. 1983; 54: 373–381
   PubMed Web of Science ®Google Scholar
• Goldman J. M., Shiota F., Th'ng K.M., Orchard K. H. Circulating granulocyte and erythroid progenitor cells in chronic granulocytic leukemia. Br. J. Haematol. 1980; 46: 7–13
   PubMed Web of Science ®Google Scholar
• Croziat H., Amato D., McLeod D. L., Eskinazi D., Axelrad A. Differences among myeloproliferative disorders in the behaviour of their restricted progenitor cells in culture. Blood 1983; 62: 578–584
   PubMed Web of Science ®Google Scholar
• Fauser A. A., Messner H. A. Pluripotent haematopoietic progenitors (CFU-GEMM) in polycythaemia vera: analysis of erythropoietin requirement and proliferative activity. Blood 1981; 58: 1224–1227
   PubMed Web of Science ®Google Scholar
• Kornberg A., Fibach E., Treves A., Goldfarb A., Rachmilewitz E. A. Circulating erythroid progenitors in patients with spent polycythaemia vera and myelofibrosis with myeloid metaplasia. Br. J. Haemal. 1982; 52: 573–578
   PubMed Web of Science ®Google Scholar
• Adams J. A., Barret A. J., McCarty B. D.M. Primary polycythaemia, essenlial thrombocythaemia and myelofibrosis—three facets of a single disease process?. Acta Haemat. 1988; 79: 33–37
   PubMed Web of Science ®Google Scholar
• Morris C. M., Fitzgerald P. M., Holling P. E., Archer S. A., Rosman I., Beard M. E. Essential thrombocythhemia and Philadelphia chromosome. Brit. J. Haemat. 1988; 70: 13–19
   PubMed Web of Science ®Google Scholar
• Morris CM., Heisterkamp N., Groffen J., Fitzgerald PH. Entire ABL gene is joined with 5′-BCR in some patients with philadelphia-positive leukemia. Blood 1991; 78: 1078–1084
   PubMed Web of Science ®Google Scholar
• Stoll D. B., Peterson P., Exton R., Laszlo J., Pisciotta A. V., Ellis J. T., White P., Vaidya K., Bozdech M., Murphy S. Clinical presentation and natural history of patients with essential thromobocythemia and the Philadelphia chromosome. Am. J. Hematol. 1988; 27: 77–83
   Web of Science ®Google Scholar
• Matriat P., Ifrah N., Rassol F., Morgan G., Giles F., Gow J., Goldman J. M. Molecular analysis of Philadelphia positive essential thrombocythemia. Leukemia 1989; 3: 563–565
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the thrombocythemia vera study group. Sem. Thrombosis and Hemostasis 1997; 23: 339–347
   Web of Science ®Google Scholar
• Marasca R., Luppi M., Zucchini P., Longo G., Torelli G., Emillia G. Might essential thrombocythemia carry Ph anomaly?. Blood 1998; 91: 3084–3089
   PubMed Web of Science ®Google Scholar
• Goldman J. M. Chronic myeloid leukemia. Curr. Opin. Hematol. 1997; 4: 277–285
   PubMedGoogle Scholar
• Vickers M. Estimation of the number of mutations necessary to cause chronic myeloid leukemia from epidemiological data. Brit. J. Haematol. 1996; 94: 1–4
   PubMed Web of Science ®Google Scholar
• Bückstein D., Aviram A., Luboshitz J., Prokocimer M., Stark P., Bairey O., Sulkes J., Shaklai M. BCR-ABL transcripts in bone marrow aspirates of philadelphia-negative essential thrombocythemia patients: Clinical presentation. Blood 1997; 90: 2768–2771
   PubMed Web of Science ®Google Scholar
• Cervantes F., Urbano Ispizua A., Villamor N., Feliu E., Milla Montserrat E., Rozman C. Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis/; Report of two cases with molecular studies. Leukemia 1993; 7: 327–330
   PubMed Web of Science ®Google Scholar
• Inokuchi K., Inoue T., Tojo A., Futaki M., Miyake K., Yamada T., Tanabe Y., Ohki I., Dan K., Ozawa K., Asano S., Nomura T. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 1991; 78: 3125–3127
   PubMed Web of Science ®Google Scholar
• Ardern JC., Speak J., Hyde K., Hunt LP., Lawson R., Gorst DW., Geary CG., Lucas G S. Molecular analysis in chronic granulocytic leukemia: location of breakpoints within M-bcr and relationship with presentation platelet count. Clin. Lab. Haematol. 1993; 15: 253–258
   Google Scholar